Delaware
|
95-4106894
|
(State or other jurisdiction
|
(I.R.S. Employer Identification No.)
|
of incorporation or organization)
|
Large Accelerated Filer
|
Accelerated Filer
|
|
Non-accelerated filer
|
Smaller Reporting Company [x]
|
Class
|
Outstanding July 8, 2013
|
Common Stock, par value $0.0001 per share
|
84,114,499 shares
|
Index
|
Page No.
|
||
PART I.
|
FINANCIAL INFORMATION
|
||
ITEM 1.
|
Financial Statements (Unaudited)
|
||
Condensed Balance Sheets as of May 31, 2013 and February 28, 2013
|
4
|
||
Condensed Statements of Operations for the Three months Ended May 31, 2013 and 2012
|
5
|
||
Condensed Statements of Cash Flows for the Three months Ended May 31, 2013 and 2012
|
6
|
||
Notes to Condensed Financial Statements
|
7
|
||
ITEM 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
14
|
|
ITEM 4T.
|
Controls and Procedures
|
18
|
|
PART II.
|
OTHER INFORMATION
|
||
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
19
|
|
ITEM 6.
|
Exhibits
|
19
|
|
SIGNATURES AND CERTIFICATIONS
|
20
|
May 31, 2013 | February 28, 2013 | |||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$ | 14,326 | $ | 89,196 | ||||
Accounts receivable, net of allowance for doubtful accounts of $50,000 and $50,000 at May 31, 2013 and February 28, 2013, respectively
|
389,947 | 279,551 | ||||||
Inventory - current
|
1,000,000 | 1,000,000 | ||||||
Other current assets
|
187,870 | 235,034 | ||||||
Total current assets
|
1,592,143 | 1,603,780 | ||||||
Deposits
|
61,944 | 61,944 | ||||||
Property, plant, and equipment, net
|
21,360 | 40,470 | ||||||
Inventory, non-current, net of allowance for obsolete inventory of $1,298,562 and $1,341,650 at May 31, 2013 and February 28, 2013, respectively
|
1,256,599 | 1,384,142 | ||||||
Total assets
|
$ | 2,932,046 | $ | 3,090,336 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$ | 1,173,695 | $ | 1,202,382 | ||||
Accrued expenses
|
1,949,417 | 1,601,740 | ||||||
Customer advances
|
64,230 | 12,598 | ||||||
Notes payable
|
1,488,990 | 3,004,990 | ||||||
Convertible notes payable, net of discount
|
1,691,467 | 503,509 | ||||||
Notes payable and accrued interest- related party
|
17,695,498 | 17,265,466 | ||||||
Total current liabilities
|
24,063,297 | 23,590,684 | ||||||
Convertible note payable, net of discount
|
1,120,354 | 1,097,938 | ||||||
Total liabilities
|
25,183,651 | 24,688,623 | ||||||
Commitments and contingencies
|
||||||||
Stockholders' deficit:
|
||||||||
Common stock, $0.0001 par value; 150,000,000 shares authorized at May 31, 2013 and February 28, 2013; 84,114,499 and 76,604,573 issued and outstanding at May 31, 2013 and February 28, 2013
|
8,411 | 7,660 | ||||||
Additional paid-in capital
|
401,274,939 | 398,949,767 | ||||||
Accumulated deficit
|
(423,534,955 | ) | (420,555,713 | ) | ||||
Total stockholders' deficit
|
(22,251,605 | ) | (21,598,286 | ) | ||||
Total liabilities and stockholders' deficit
|
$ | 2,932,046 | $ | 3,090,336 | ||||
May 31, 2013
|
May 31, 2012 | |||||||
Net Revenues
|
$ | 808,526 | $ | 767,568 | ||||
Cost of goods sold
|
320,220 | 353,111 | ||||||
Gross Profit
|
488,306 | 414,457 | ||||||
Operating expenses:
|
||||||||
Engineering, research and development expenses
|
398,798 | 316,491 | ||||||
Selling, general and administrative expenses
|
2,565,170 | 2,300,302 | ||||||
Total operating expenses
|
2,963,968 | 2,616,793 | ||||||
Loss from operations
|
(2,475,662 | ) | (2,202,336 | ) | ||||
Other (income) and expense:
|
||||||||
Interest expense, net
|
716,298 | 880,897 | ||||||
Other income, net
|
(212,717 | ) | (1,500 | ) | ||||
Total other (income) expense
|
503,581 | 879,397 | ||||||
Net Loss
|
$ | (2,979,243 | ) | $ | (3,081,733 | ) | ||
Total basic and diluted loss per share
|
$ | (0..04 | ) | $ | (0.04 | ) | ||
Weighted average shares used to compute basic and diluted loss per share
|
77,521,286 | 72,052,995 | ||||||
2013
|
2012
|
|||||||
Cash flow from operating activities:
|
||||||||
Net Loss
|
$ | (2,979,243 | ) | $ | (3,081,733 | ) | ||
Adjustments to reconcile Net loss to net cash used in operating activities
|
||||||||
Depreciation Expense
|
19,110 | 45,263 | ||||||
Debt discount | (753,798 | ) | - | |||||
Amortization of debt discount
|
224,723 | 590,207 | ||||||
Gain on conversion | (203,110 | ) | ||||||
Stock issued for services
|
297,725 | 266,000 | ||||||
Provision for inventory obsolescence
|
(43,088 | ) | (104,886 | ) | ||||
Amortization of prepaid shares
|
- | 95,193 | ||||||
Stock options and warrants expense
|
901,195 | 63,828 | ||||||
(Increase) decrease in:
Accounts receivable
|
(110,396 | ) | 54,106 | |||||
Inventory
|
170,631 | 169,961 | ||||||
Other current assets and deposit
|
47,164 | 62,153 | ||||||
Increase (decrease) in:
|
||||||||
Accounts payable, customer deposit and accrued expenses
|
777,765 | 656,894 | ||||||
Net cash used in operations
|
(1,651,320 | ) | (1,183,014 | ) | ||||
Financing activities:
|
||||||||
Proceeds from notes payable
|
955,000 | - | ||||||
Proceeds from convertible notes payable | 845,700 | |||||||
Payments on notes payable
|
(306,250 | ) | (612,500 | ) | ||||
Proceeds from notes payable-related party, net
|
82,000 | 1,800,000 | ||||||
Net cash provided by financing activities:
|
1,576,450 | 1,187,500 | ||||||
Net increase in cash & cash equivalents
|
(74,870 | ) | 4,486 | |||||
Cash and cash equivalents at beginning of period
|
89,196 | 6,260 | ||||||
Cash and cash equivalents at end of period
|
$ | 14,326 | $ | 10,746 | ||||
Supplemental disclosures of cash flow information
|
||||||||
Cash paid during the period for:
|
||||||||
Interest
|
$ | 45,031 | $ | - | ||||
Income taxes
|
- | - |
May 31, 2012
|
February 28, 2013
|
|||||||
Raw materials
|
$ | 1,787,765 | $ | 1,888,831 | ||||
Finished goods
|
1,767,396 | 1,836,960 | ||||||
3,555,161 | 3,725,791 | |||||||
Reserve for potential product obsolescence
|
(1,218,353 | ) | (1,253,300 | ) | ||||
Discount on long term inventory
|
(80,209 | ) | (88,350 | ) | ||||
2,256,599 | 2,384,141 | |||||||
Non-current portion
|
(1,256,599 | ) | (1,384,141 | ) | ||||
Current portion
|
$ | 1,000,000 | $ | 1,000,000 | ||||
May 31, 2013
|
February 28, 2013
|
|||||||
Machinery and equipment
|
$ | 964,111 | $ | 964,111 | ||||
Furniture and fixtures
|
163,302 | 163,302 | ||||||
Leasehold improvements
|
485,080 | 485,080 | ||||||
1,612,493 | 1,612,493 | |||||||
Less accumulated depreciation
|
(1,591,133 | ) | (1,572,023 | ) | ||||
Property, plant and equipment, net
|
$ | 21,360 | $ | 40,470 |
May 31, 2013
|
February 28, 2013
|
|||||||
Demand notes payable, at 10% and 16%
|
$ | 1,488,990 | $ | 3,004,990 | ||||
Convertible Promissory Note dated August 10, 2012, due August 10, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 10th of each month with the principal payment due on the maturity date.
|
739,592 | 724,056 | ||||||
Convertible Promissory Note dated October 2, 2012, due October 2, 2017, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.
|
380,762 | 373,882 | ||||||
Convertible Promissory Note dated November 2, 2012, due January 4, 2013, convertible into shares of our common stock at a price of $0.76 per share. The note carries an interest rate of 7% with interest only payments due on the 2nd of each month with the principal payment due on the maturity date.
|
- | 350,000 | ||||||
Senior secured convertible note dated September 23, 2011, due March 23, 2013, with 12 monthly payments commencing April 23, 2012 of $306,250 per month. The notes have a stated interest rate of 0%, with prepaid interest of $175,000. Balance net of Beneficial Conversion Feature
|
- | 153,508 | ||||||
Senior secured convertible notes dated May 7, 2013, due June 15, 2013, convertible into shares of our common stock at a price of $0.75 per share. The notes carry an interest rate of 12% with interest due on the last day of the month. If the note is not repaid by the due date, the interest rate increases to 16%.
|
1,691,467 | - | ||||||
4,300,811 | 4,606,436 | |||||||
Less: Current portion
|
$ | 3,180,457 | $ | 3,508,498 | ||||
Long-term portion
|
$ | 1,120,354 | $ | 1,097,938 |
Year Ending February 28,
|
||||
2014
|
$ |
-
|
||
2015
|
-
|
|||
2016
|
-
|
|||
2017
|
1,120,354
|
|||
Total
|
$ |
1,120,354
|
May 31, 2013
|
February 28, 2013
|
|||||||
Accrued payroll and related expenses
|
$ | 1,899,295 | $ | 1,564,496 | ||||
Accrued interest
|
42,501 | 30,867 | ||||||
Other
|
7,621 | 6,377 | ||||||
Total
|
$ | 1,949,417 | $ | 1,601,740 |
2006 Plan
|
|||||||
Weighted-Average Exercise Price
|
Aggregate Intrinsic Value
|
Number of Options
|
|||||
[Missing Graphic Reference]
|
[Missing Graphic Reference]
|
[Missing Graphic Reference]
|
|||||
Outstanding, February 28, 2013
|
$0.75-$1.00
|
$0.00
|
8,548,000
|
||||
Cancelled
|
-
|
-
|
|||||
Granted
|
-
|
-
|
|||||
Outstanding, May 31, 2013
|
$0.75-$1.00
|
$0.00
|
8,548,000
|
Options Outstanding
|
Exercisable Options
|
||||||||||||||||||
Range of Exercise
Price
|
Number
|
Weighted Average Remaining Life
|
Weighted Average Exercise Price
|
Weighted Average Remaining Life
|
Number
|
Weighted Average Exercise Price
|
|||||||||||||
$0.75-$1.00
|
8,548,000
|
6.65 years
|
$
|
0.79
|
6.75 years
|
8,048,000
|
$
|
0.79
|
Number of Shares
|
Exercise Prices
|
||
Outstanding, February 28, 2013
|
38,783,290
|
$0.75-$4.00
|
|
Granted
|
3,368,762
|
$0.75
|
|
Cancelled
|
(5,005,000)
|
$0.75
|
|
Outstanding, May 31, 2013
|
37,147,052
|
$0.75-$4.00
|
Range of Exercise Prices
|
Stock Warrants Outstanding
|
Stock Warrants Exercisable
|
Weighted-Average Remaining Contractual Life
|
Weighted-Average Exercise Price of Warrants Outstanding
|
Weighted-Average Exercise Price of Warrants Exercisable
|
Intrinsic Value
|
||||||
$0.75
|
3,368,762
|
3,368,762
|
83 months
|
$0.75
|
$0.75
|
$0.00
|
||||||
$0.75-$1.00
|
8,756,942
|
8,756,942
|
74 months
|
$0.81
|
$0.81
|
$0.00
|
||||||
$1.00-$1.25
|
1,220,000
|
1,220,000
|
40 months
|
$1.03
|
$1.03
|
$0.00
|
||||||
$1.00
|
16,722,787
|
16,722,787
|
39 months
|
$1.00
|
$1.00
|
$0.00
|
||||||
$1.50
|
155,000
|
155,000
|
34 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
$0.75-1.50
|
1,109,198
|
1,109,198
|
31 months
|
$1.17
|
$1.17
|
$0.00
|
||||||
$1.50
|
156,000
|
156,000
|
27 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
$1.50
|
704,000
|
704,000
|
26 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
$1.50
|
350,642
|
350,642
|
23 months
|
$1.50
|
$1.50
|
$0.00
|
||||||
$0.75-$2.00
|
58,000
|
58,000
|
19 months
|
$1.78
|
$1.78
|
$0.00
|
||||||
$2.00
|
725,721
|
725,721
|
16 months
|
$2.00
|
$2.00
|
$0.00
|
||||||
$0.75-2.00
|
3,650,000
|
3,650,000
|
13 months
|
$1.03
|
$1.03
|
$0.00
|
||||||
$3.00
|
170,000
|
170,000
|
6 months
|
$3.00
|
$3.00
|
$0.00
|
||||||
37,147,052
|
37,147,052
|
2013
|
2012
|
|||||||
United States
|
$ | 616,227 | $ | 500,368 | ||||
Canada
|
48,060 | 21,050 | ||||||
Europe
|
4,136 | 61,664 | ||||||
Asia
|
131,353 | 148,042 | ||||||
Other
|
8,750 | 36,444 | ||||||
Total
|
$ | 808,526 | $ | 767,568 |
·
|
Our ability to generate positive cash flow from operations;
|
·
|
Our ability to obtain additional financing to fund our operations;
|
·
|
Our business development and operating development; and
|
·
|
Our expectations of growth in demand for our products.
|
By:
|
/s/ Melvin Gagerman
|
Melvin Gagerman
|
|
Chief Executive Officer
|
|
By:
|
/s/ Melvin Gagerman
|
Melvin Gagerman
|
|
Chief Financial Officer
|
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods indicated.
|
Date: July 22, 2013
|
By:
|
/s/ Melvin Gagerman
|
Melvin Gagerman
Chief Executive Officer, Chief
Financial Officer, Chief Accounting
Officer
|
SIGNIFICANT CUSTOMERS
|
3 Months Ended |
---|---|
May 31, 2013
|
|
SIGNIFICANT CUSTOMERS [Abstract] | |
SIGNIFICANT CUSTOMERS | NOTE 11 – SIGNIFICANT CUSTOMERS Concentration Risk In the three months ended May 31, 2013, we sold AuraGen related products to four significant customers whose sales comprised 32%, 16%, 15% and 13% of net sales, respectively. Net accounts receivable from these customers at May 31, 2013 were $165,280, $0, $90,279, and $47,163 respectively. These customers are not related to or affiliated with us. In the three months ended May 31, 2012, we sold AuraGen related products to four significant customers whose sales comprised 21%, 19%, 10% and 9% of net sales, respectively. Net accounts receivable from these customers at May 31, 2012 were $110,625, $467,125, $3,864 and $71,688 respectively. These customers are not related to or affiliated with us. |
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
|
3 Months Ended | |
---|---|---|
May 31, 2013
|
May 31, 2012
|
|
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) [Abstract] | ||
Net revenues | $ 808,526 | $ 767,568 |
Cost of goods sold | 320,220 | 353,111 |
Gross profit | 488,306 | 414,457 |
Operating expenses: | ||
Engineering, research and development | 398,798 | 316,491 |
Selling, general and administrative | 2,565,170 | 2,300,302 |
Total operating expenses | 2,963,968 | 2,616,793 |
Loss from operations | (2,475,662) | (2,202,336) |
Other income (expense): | ||
Interest expense, net | 716,298 | 880,897 |
Other income, net | (212,717) | (1,500) |
Total other (income) expense | 503,581 | 879,397 |
Net Loss | $ (2,979,243) | $ (3,081,733) |
Total basic and diluted loss per share (in dollars per share) | $ (0.04) | $ (0.04) |
Weighted average shares used to compute basic and diluted loss per share (in shares) | 77,521,286 | 72,052,995 |
OTHER CURRENT ASSETS
|
3 Months Ended |
---|---|
May 31, 2013
|
|
OTHER ASSETS [Abstract] | |
OTHER ASSETS | NOTE 4 – OTHER CURRENT ASSETS Other assets of $187,870 and $235,034 are primarily comprised short term deposits of $147,110 and $181,910 as of May 31, 2013 and February 28, 2013. |
SHAREHOLDERS EQUITY (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHAREHOLDERS' EQUITY [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock option activity | In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exercise price of options outstanding and options information | The exercise prices for the options outstanding at May 31, 2013, and information relating to these options is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants Activity | Activity in issued and outstanding warrants is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exercise prices for the warrants outstanding and warrant information | The exercise prices for the warrants outstanding at May 31, 2013, and information relating to these warrants is as follows:
|
RELATED PARTY TRANSACTIONS
|
3 Months Ended |
---|---|
May 31, 2013
|
|
RELATED PARTY TRANSACTIONS [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 12 – RELATED PARTIES TRANSACTIONS At May 31, 2013, the balance includes $13,819,960 of unsecured notes payable plus accrued interest of $3,792,288 to a member of our Board of Directors, payable on demand, bearing interest at a rate of 10% per annum. During the three months ended May 31, 2013 and May 31, 2012, interest amounting to $346,782 and $283,084 respectively, was incurred on these notes. The balance also includes $82,000 of unsecured notes payable plus accrued interest of $1,250 to our CEO pursuant to a demand note entered into on April 5, 2013. |
INVENTORIES (Details) (USD $)
|
May 31, 2013
|
Feb. 28, 2013
|
---|---|---|
INVENTORIES [Abstract] | ||
Raw materials | $ 1,787,765 | $ 1,888,831 |
Finished goods | 1,767,396 | 1,836,960 |
Inventory gross current and noncurrent portion | 3,555,161 | 3,725,791 |
Reserve for potential product obsolescence | (1,218,353) | (1,253,300) |
Discount on long term inventory | (80,209) | (88,350) |
Total inventory, net | 2,256,599 | 2,384,141 |
Non-current portion | (1,256,599) | (1,384,141) |
Current portion | $ 1,000,000 | $ 1,000,000 |
GOING CONCERN (Details) (USD $)
|
3 Months Ended | |
---|---|---|
May 31, 2013
|
May 31, 2012
|
|
GOING CONCERN [Abstract] | ||
Net Loss | $ 2,979,243 | $ 3,081,733 |
Cash flows from operating activities | $ 1,651,320 | $ 1,183,014 |
SEGMENT INFORMATION (Details) (USD $)
|
3 Months Ended | |
---|---|---|
May 31, 2013
Segment
|
May 31, 2012
|
|
Segment Reporting , Revenue Reconciling Item [Line Items] | ||
Number of Operating Segments | 1 | |
Revenues from customer geographical segments [Abstract] | ||
United States | $ 616,227 | $ 500,368 |
Total | 808,526 | 767,568 |
Canada [Member]
|
||
Revenues from customer geographical segments [Abstract] | ||
Foreign countries | 48,060 | 21,050 |
Europe [Member]
|
||
Revenues from customer geographical segments [Abstract] | ||
Foreign countries | 4,136 | 61,664 |
Other [Member]
|
||
Revenues from customer geographical segments [Abstract] | ||
Foreign countries | 8,750 | 36,444 |
Asia [Member]
|
||
Revenues from customer geographical segments [Abstract] | ||
Foreign countries | $ 131,353 | $ 148,042 |
ACCRUED EXPENSES (Details) (USD $)
|
May 31, 2013
|
Feb. 28, 2013
|
---|---|---|
Accrued expenses [Abstract] | ||
Accrued payroll and related expenses | $ 1,899,295 | $ 1,564,496 |
Accrued interest | 42,501 | 30,867 |
Other | 7,621 | 6,377 |
Total | 1,949,417 | 1,601,740 |
Accrued payroll and related expenses | 1,205,215 | 1,927,984 |
Accrued vacation expense | $ 449,509 | $ 411,667 |
SEGMENT INFORMATION (Tables)
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT INFORMATION [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenues from customer geographical segments | Total net revenues from customer geographical segments are as follows for the three months ended May 31, 2013 and 2012:
|
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical) (USD $)
|
3 Months Ended |
---|---|
May 31, 2013
|
|
Supplemental disclosure of non-cash investing and financing activities: | |
Common stock issued (in shares) | 4,254,250 |
Cancellation of warrants to purchase shares of common stock | 5,005,000 |
Common stock, Exercise Price | $ 0.75 |
Notes Payable and Accrued Interest [Member]
|
|
Supplemental disclosure of non-cash investing and financing activities: | |
Notes payable and accrued interest were converted | $ 1,330,112 |
Common stock issued (in shares) | 2,660,225 |
Services Rendered [Member]
|
|
Supplemental disclosure of non-cash investing and financing activities: | |
Common stock issued (in shares) | 595,451 |
Liability converted into common shares | $ 297,726 |
GOING CONCERN
|
3 Months Ended |
---|---|
May 31, 2013
|
|
GOING CONCERN [Abstract] | |
GOING CONCERN | NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. During the three months ended May 31, 2013 and May 31, 2012, the Company incurred losses of $2,979,243 and $3,081,733, respectively and had negative cash flows from operating activities of $1,651,320 and $1,183,014, respectively. If the Company is unable to generate profits and is unable to continue to obtain financing for its working capital requirements, it may have to curtail its business sharply or cease business altogether. Substantial additional capital resources will be required to fund continuing expenditures related to our research, development, manufacturing and business development activities. The Company's continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to retain its current financing, to obtain additional financing, and ultimately to attain profitability. The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that could result from the outcome of this uncertainty. During the next twelve months we intend to continue to expand our AuraGen/Viper business both domestically and internationally. There are four major components necessary to execute a significantly expanding business; (i) augmentation of management and staff, (ii) purchase orders, (iii) facilities and equipment, and (iv) working capital. We plan to add senior quality assurance and quality control staff as well as a number of mechanical and electrical engineers, a number of technicians, and a number of test engineers. We had planned to take these steps in the current fiscal year, but a lack of resources prevented us from doing so. We anticipate being able to fund these additions in the upcoming fiscal year. |
PROPERTY, PLANT, AND EQUIPMENT
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PROPERTY, PLANT, AND EQUIPMENT [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PROPERTY, PLANT, AND EQUIPMENT | NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT Property, plant, and equipment consisted of the following:
Depreciation expense was $19,110 and $45,263 for the three months ended May 31, 2013 and May 31, 2012, respectively. |
INVENTORIES
|
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2013
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVENTORIES [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVENTORIES | NOTE 3 – INVENTORIES Inventories, stated at the lower of cost (first in first out), or market consisted of the following:
We assessed the net realize-ability and the related potential obsolescence of inventory. In accordance with this assessment, management has recorded a reserve of $1,218,353 and $1,253,300 as of May 31, 2013 and February 28, 2013, respectively. Management has also recorded a discount on long term inventory of $80,209 and $88,350 as of May 31, 2013 and February 28, 2013, respectively. |
OTHER CURRENT ASSETS (Details) (USD $)
|
May 31, 2013
|
Feb. 28, 2013
|
---|---|---|
OTHER ASSETS [Abstract] | ||
Other current assets | $ 187,870 | $ 235,034 |
Short term deposits | $ 147,110 | $ 181,910 |
SHAREHOLDERS EQUITY (Details) (USD $)
|
3 Months Ended | 3 Months Ended | 3 Months Ended | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 31, 2013
|
May 31, 2012
|
Sep. 23, 2011
|
May 31, 2013
Exercise Price Range $0.75 and 83 Months [Member]
|
May 31, 2013
Exercise Price Range $0.75-$1.00 and 74 Months [Member]
|
May 31, 2013
Exercise Price Range $1.00-$1.25 and 40 Months [Member]
|
May 31, 2013
Exercise Price Range $1.00 and 39 Months [Member]
|
May 31, 2013
Exercise Price Range $1.50 and 34 Months [Member]
|
May 31, 2013
Exercise Price Range $0.75-1.50 and 31 Months [Member]
|
May 31, 2013
Exercise Price Range $1.50 and 27 Months [Member]
|
May 31, 2013
Exercise Price Range $1.50 and 26 Months [Member]
|
May 31, 2013
Exercise Price Range $1.50 and 23 Months [Member]
|
May 31, 2013
Exercise Price Range $0.75-$2.00 and 19 Months [Member]
|
May 31, 2013
Exercise Price Range $2.00 and 16 Months [Member]
|
May 31, 2013
Exercise Price Range $0.75-$2.00 and 13 Months [Member]
|
May 31, 2013
Exercise Price Range $3.00 and 6 Months [Member]
|
May 31, 2013
Employee Stock Option Plan 2006 [Member]
|
May 31, 2013
Warrant [Member]
|
May 31, 2013
Minimum [Member]
Exercise Price Range $0.75-$1.00 and 74 Months [Member]
|
May 31, 2013
Minimum [Member]
Exercise Price Range $1.00-$1.25 and 40 Months [Member]
|
May 31, 2013
Minimum [Member]
Exercise Price Range $0.75-1.50 and 31 Months [Member]
|
May 31, 2013
Minimum [Member]
Exercise Price Range $0.75-$2.00 and 19 Months [Member]
|
May 31, 2013
Minimum [Member]
Exercise Price Range $0.75-$2.00 and 13 Months [Member]
|
May 31, 2013
Minimum [Member]
Employee Stock Option Plan 2006 [Member]
|
Feb. 28, 2013
Minimum [Member]
Employee Stock Option Plan 2006 [Member]
|
May 31, 2013
Minimum [Member]
Warrant [Member]
|
Feb. 28, 2013
Minimum [Member]
Warrant [Member]
|
May 31, 2013
Maximum [Member]
Exercise Price Range $0.75-$1.00 and 74 Months [Member]
|
May 31, 2013
Maximum [Member]
Exercise Price Range $1.00-$1.25 and 40 Months [Member]
|
May 31, 2013
Maximum [Member]
Exercise Price Range $0.75-1.50 and 31 Months [Member]
|
May 31, 2013
Maximum [Member]
Exercise Price Range $0.75-$2.00 and 19 Months [Member]
|
May 31, 2013
Maximum [Member]
Exercise Price Range $0.75-$2.00 and 13 Months [Member]
|
May 31, 2013
Maximum [Member]
Employee Stock Option Plan 2006 [Member]
|
Feb. 28, 2013
Maximum [Member]
Employee Stock Option Plan 2006 [Member]
|
May 31, 2013
Maximum [Member]
Warrant [Member]
|
Feb. 28, 2013
Maximum [Member]
Warrant [Member]
|
May 31, 2013
Notes Payable and Accrued Interest [Member]
|
May 31, 2013
Services Rendered [Member]
|
May 31, 2012
Services Rendered [Member]
|
May 31, 2013
Cancellation of warrants [Member]
|
|
Common Stock [Abstract] | ||||||||||||||||||||||||||||||||||||||||
Common Stock issued for cash consideration (in shares) | 595,451 | 350,000 | ||||||||||||||||||||||||||||||||||||||
Other Significant Noncash Transactions [Line Items] | ||||||||||||||||||||||||||||||||||||||||
Liability converted into common shares | $ 1,330,112 | $ 297,726 | $ 266,000 | |||||||||||||||||||||||||||||||||||||
Common stock issued on conversion of liability (in shares) | 2,660,225 | 595,451 | 4,254,250 | |||||||||||||||||||||||||||||||||||||
Price per share of shares issued (in dollars per share) | $ 0.75 | $ 0.75 | ||||||||||||||||||||||||||||||||||||||
Weighted-Average Exercise Price [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
Outstanding, Beginning Balance (in dollars per share) | $ 0.75 | $ 0.75 | $ 1.00 | $ 1.00 | ||||||||||||||||||||||||||||||||||||
Cancelled (in dollars per share) | $ 0 | |||||||||||||||||||||||||||||||||||||||
Granted (in dollars per share) | $ 0 | |||||||||||||||||||||||||||||||||||||||
Outstanding, Ending Balance (in dollars per share) | $ 0.75 | $ 0.75 | $ 1.00 | $ 1.00 | ||||||||||||||||||||||||||||||||||||
Aggregate Intrinsic Value [Abstract] | ||||||||||||||||||||||||||||||||||||||||
Outstanding, Beginning Balance | 0.00 | |||||||||||||||||||||||||||||||||||||||
Outstanding, Ending Balance | $ 0.00 | |||||||||||||||||||||||||||||||||||||||
Number of Options [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
Outstanding, Beginning Balance (in shares) | 8,548,000 | |||||||||||||||||||||||||||||||||||||||
Cancelled (in shares) | 0 | |||||||||||||||||||||||||||||||||||||||
Granted (in shares) | 0 | |||||||||||||||||||||||||||||||||||||||
Outstanding, Ending Balance (in shares) | 8,548,000 | |||||||||||||||||||||||||||||||||||||||
Exercise prices for outstanding options and option information [Abstract] | ||||||||||||||||||||||||||||||||||||||||
Range of Exercise Price (in dollars per share) | $ 0.75 | $ 0.75 | $ 1.00 | $ 1.00 | ||||||||||||||||||||||||||||||||||||
Options Outstanding, Number (in shares) | 8,548,000 | |||||||||||||||||||||||||||||||||||||||
Options Outstanding, Weighted Average Remaining Life | 6 years 7 months 24 days | |||||||||||||||||||||||||||||||||||||||
Options Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 0.79 | |||||||||||||||||||||||||||||||||||||||
Exercisable Options, Weighted Average Remaining Life | 6 years 9 months | |||||||||||||||||||||||||||||||||||||||
Exercisable Options, Number (in shares) | 8,048,000 | |||||||||||||||||||||||||||||||||||||||
Exercisable Options, Weighted Average Exercise Price (in dollars per share) | $ 0.79 | |||||||||||||||||||||||||||||||||||||||
Number of Shares [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
Beginning Balance (in shares) | 38,783,290 | |||||||||||||||||||||||||||||||||||||||
Granted (in shares) | 3,368,762 | |||||||||||||||||||||||||||||||||||||||
Cancelled (in shares) | (5,005,000) | |||||||||||||||||||||||||||||||||||||||
Ending Balance (in shares) | 37,147,052 | 3,368,762 | 8,756,942 | 1,220,000 | 16,722,787 | 155,000 | 1,109,198 | 156,000 | 704,000 | 350,642 | 58,000 | 725,721 | 3,650,000 | 170,000 | 37,147,052 | |||||||||||||||||||||||||
Exercise Prices [Abstract] | ||||||||||||||||||||||||||||||||||||||||
Outstanding, Beginning Balance (in dollars per share) | $ 0.75 | $ 1.00 | $ 0.75 | $ 0.75 | $ 0.75 | $ 0.75 | $ 0.75 | $ 1.00 | $ 1.25 | $ 1.50 | $ 2.00 | $ 2.00 | $ 4.00 | $ 4.00 | ||||||||||||||||||||||||||
Granted (in dollars per share) | $ 0.75 | |||||||||||||||||||||||||||||||||||||||
Cancelled (in dollars per share) | $ 0.75 | |||||||||||||||||||||||||||||||||||||||
Outstanding, Ending Balance (in dollars per share) | $ 0.75 | $ 1.00 | $ 1.50 | $ 1.50 | $ 1.50 | $ 1.50 | $ 2.00 | $ 3.00 | $ 0.75 | $ 1.00 | $ 0.75 | $ 0.75 | $ 0.75 | $ 0.75 | $ 0.75 | $ 1.00 | $ 1.25 | $ 1.50 | $ 2.00 | $ 2.00 | $ 4.00 | $ 4.00 | ||||||||||||||||||
Exercise prices for warrants outstanding and warrant information [Abstract] | ||||||||||||||||||||||||||||||||||||||||
Range of Exercise Prices (in dollars per share) | $ 0.75 | $ 1.00 | $ 1.50 | $ 1.50 | $ 1.50 | $ 1.50 | $ 2.00 | $ 3.00 | $ 0.75 | $ 1.00 | $ 0.75 | $ 0.75 | $ 0.75 | $ 0.75 | $ 0.75 | $ 1.00 | $ 1.25 | $ 1.50 | $ 2.00 | $ 2.00 | $ 4.00 | $ 4.00 | ||||||||||||||||||
Stock Warrants Outstanding (in shares) | 37,147,052 | 3,368,762 | 8,756,942 | 1,220,000 | 16,722,787 | 155,000 | 1,109,198 | 156,000 | 704,000 | 350,642 | 58,000 | 725,721 | 3,650,000 | 170,000 | 37,147,052 | |||||||||||||||||||||||||
Stock Warrants Exercisable (in shares) | 37,147,052 | 3,368,762 | 8,756,942 | 1,220,000 | 16,722,787 | 155,000 | 1,109,198 | 156,000 | 704,000 | 350,642 | 58,000 | 725,721 | 3,650,000 | 170,000 | ||||||||||||||||||||||||||
Weighted-Average Remaining Contractual Life | 6 years 11 months | 6 years 2 months | 3 years 4 months | 3 years 3 months | 2 years 10 months | 2 years 7 months | 2 years 3 months | 2 years 2 months | 1 year 11 months | 1 year 7 months | 1 year 4 months | 1 year 1 month | 6 months | |||||||||||||||||||||||||||
Weighted-Average Exercise Price of Warrants Outstanding (in dollars per share) | $ 0.75 | $ 0.81 | $ 1.03 | $ 1.00 | $ 1.50 | $ 1.17 | $ 1.50 | $ 1.50 | $ 1.50 | $ 1.78 | $ 2.00 | $ 1.03 | $ 3.00 | |||||||||||||||||||||||||||
Weighted-Average Exercise Price of Warrants Exercisable (in dollars per share) | $ 0.75 | $ 0.81 | $ 1.03 | $ 1.00 | $ 1.50 | $ 1.17 | $ 1.50 | $ 1.50 | $ 1.50 | $ 1.78 | $ 2.00 | $ 1.03 | $ 3.00 | |||||||||||||||||||||||||||
Intrinsic Value (in dollars per share) | $ 0.00 |
'0O
M:'1M;#L@8VAA '0O:'1M;#L@8VAA '0O:'1M;#L@8VAA